Non-Invasive Characterization of the Pancreas During Bariatric Surgery
bariatric surgery
cfmRNA
liquid biospsy
metabolic health
pancreas
Journal
Frontiers in genetics
ISSN: 1664-8021
Titre abrégé: Front Genet
Pays: Switzerland
ID NLM: 101560621
Informations de publication
Date de publication:
2021
2021
Historique:
received:
16
07
2021
accepted:
10
09
2021
entrez:
28
10
2021
pubmed:
29
10
2021
medline:
29
10
2021
Statut:
epublish
Résumé
Bariatric surgery results in sustained weight loss and improvement in glucose homeostasis. However, the lack of accessible non-invasive tools to examine molecular alterations occurring in the pancreas limits our understanding of the causes and recovery of glucose homeostasis. Here, we describe the use of a circulating cell free mRNA (cfmRNA) based multiplex qPCR assay to selectively amplify and quantify circulating pancreatic specific transcripts levels within plasma. We applied this assay to a cohort of 58 plasma samples consisting of 10 patients that tracks multiple time points including pre and post-bariatric surgery. In our targeted multiplex screen of 14 selected pancreatic specific circulating transcripts, we identified 13 pancreatic specific transcripts that can be amplified from plasma. Furthermore, when quantifying the amplicons obtained in the short-term post-surgery (2 weeks-1 month) and long-term (3-12 months), we observed a consistent reduction of circulating GCG transcripts during short term post-surgery. Across the cohort, GCG cfmRNA levels correlated significantly with common metrics of improvement following bariatric surgery such as: haemoglobin A1c levels (R: -0.41,
Identifiants
pubmed: 34707641
doi: 10.3389/fgene.2021.742496
pii: 742496
pmc: PMC8542674
doi:
Types de publication
Journal Article
Langues
eng
Pagination
742496Informations de copyright
Copyright © 2021 Kiat Whye, ShyongTai, Shabbir, Khoo and Koh.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
Nat Commun. 2021 Jan 4;12(1):110
pubmed: 33397977
Proc Natl Acad Sci U S A. 2014 May 20;111(20):7361-6
pubmed: 24799715
Mol Metab. 2020 Jul;37:100990
pubmed: 32278655
Anal Biochem. 2012 Feb 1;421(1):81-5
pubmed: 22155054
Am J Physiol Gastrointest Liver Physiol. 2021 Apr 1;320(4):G439-G449
pubmed: 33501884
Diabetologia. 2015 Oct;58(10):2254-8
pubmed: 26186884
Nat Commun. 2020 Jan 21;11(1):400
pubmed: 31964864
Nat Commun. 2021 Apr 21;12(1):2357
pubmed: 33883548
Cell Metab. 2016 Oct 11;24(4):593-607
pubmed: 27667667
PLoS One. 2020 Nov 5;15(11):e0241803
pubmed: 33152031
Sci Adv. 2020 Dec 9;6(50):
pubmed: 33298436
Gastroenterology. 2012 Oct;143(4):897-912
pubmed: 22885332
Nat Methods. 2006 Jul;3(7):545-50
pubmed: 16791213
J Pathol. 2008 Dec;216(4):387-93
pubmed: 18853439
Nat Biotechnol. 2010 Dec;28(12):1248-50
pubmed: 21139605
Nucleic Acids Res. 1996 Jun 1;24(11):2080-6
pubmed: 8668539